Neurotransmitter control of islet hormone pulsatility
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Pulsatile secretion is an inherent property of hormone‐releasing pancreatic islet cells. This secretory pattern is physiologically important and compromised in diabetes. Neurotransmitters released from islet cells may shape the pulses in auto/paracrine feedback loops. Within islets, glucose‐stimulated β ‐cells couple via gap junctions to generate synchronized insulin pulses. In contrast, α‐ and δ‐cells lack gap junctions, and glucagon release from islets stimulated by lack of glucose is non‐pulsatile. Increasing glucose concentrations gradually inhibit glucagon secretion by α‐cell‐intrinsic mechanism/s. Further glucose elevation will stimulate pulsatile insulin release and co‐secretion of neurotransmitters. Excitatory ATP may synchronize β ‐cells with δ‐cells to generate coinciding pulses of insulin and somatostatin. Inhibitory neurotransmitters from β ‐ and δ‐cells can then generate antiphase pulses of glucagon release. Neurotransmitters released from intrapancreatic ganglia are required to synchronize β ‐cells between islets to coordinate insulin pulsatility from the entire pancreas, whereas paracrine intra‐islet effects still suffice to explain coordinated pulsatile release of glucagon and somatostatin. The present review discusses how neurotransmitters contribute to the pulsatility at different levels of integration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044 · cited 2×
“In several studies, exogenous amylin inhibits insulin release, whereas there was no effect in others [38].”
BackgroundGlucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670 · cited 1×
“Although insufficient secretion of insulin is the generally accepted cause of diabetes, it was recently proposed that ‘glucagon excess, rather than insulin deficiency, is the sine qua non of diabetes’ [3].”
BackgroundRegulation of Insulin Secretion in Human Pancreatic Islets
Rorsman, P., & Braun, M. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183754 · Cited by 599 · cited 1×
“The resulting increase of the ATP/ADP ratio leads to the closure of ATP-sensitive K+ (KATP) channels, depolarization of the plasma membrane and opening of voltage-dependent Ca2+ channels [11,12].”
BackgroundLoss-of-function mutations in SLC30A8 protect against type 2 diabetes
Go-T2D Consortium, Flannick, J., T2D-GENES Consortium, Thorleifsson, G., Beer, N. L., Jacobs, S. B. R., Grarup, N., Burtt, N. P., Mahajan, A., Fuchsberger, C., et al. (2014) · Nature Genetics · doi:10.1038/ng.2915 · Cited by 492 · cited 4×
“The release of these hormones from the islets of Langerhans is therefore essential for normal glucose homeostasis, and secretion disturbances underlie development of type 2 diabetes (T2D), which is increasing worldwide in an almost epidemic manner.”
BackgroundInfluentialMetabolic Fate of Glucose in Purified Islet Cells
Schuit, F., De Vos, A., Farfari, S., Moens, K., Pipeleers, D., Brun, T., & Prentki, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18572 · Cited by 421 · cited 1×
“Since glycolysis is essentially aerobic in β- and anaerobic in α-cells [66], glucose induces much smaller changes in cytoplasmic ATP in α-cells [31].”
BackgroundBrief, Irregular Oscillations of Basal Plasma Insulin and Glucose Concentrations in Diabetic Man
Lang, D. A., Matthews, D. R., Burnett, M., & Turner, R. C. (1981) · Diabetes · doi:10.2337/diab.30.5.435 · Cited by 279
γ-Aminobutyric Acid (GABA) Is an Autocrine Excitatory Transmitter in Human Pancreatic β-Cells
Braun, M., Ramracheya, R., Bengtsson, M., Clark, A., Walker, J. N., Johnson, P. R., & Rorsman, P. (2010) · Diabetes · doi:10.2337/db09-0797 · Cited by 239 · cited 2×
“However, during glucose stimulation, the β-cell depolarizes sufficiently to pass the Cl− reversal potential, and GABAA activation will become hyperpolarizing and inhibitory at high glucose concentrations [29].”
BackgroundRegulation of calcium in pancreatic α- and β-cells in health and disease
Rorsman, P., Braun, M., & Zhang, Q. (2012) · Cell Calcium · doi:10.1016/j.ceca.2011.11.006 · Cited by 220 · cited 2×
“A dominating hypothesis for α-cell-intrinsic regulation of glucagon secretion by glucose attributes a similar role to the KATP channels as in glucose control of insulin release from the β-cells [67].”
BackgroundGlucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells
Vieira, E., Salehi, A., & Gylfe, E. (2007) · Diabetologia · doi:10.1007/s00125-006-0511-1 · Cited by 218 · cited 6×
“Unexpectedly, however, studies in three different laboratories using a somatostatin receptor antagonist [65] or pertussis toxin blockade of somatostatin signal transduction [78,79] indicate that somatostatin exerts a tonic inhibitory effect but does not mediate glucose inhibition in this low range of glucose concentra…”
BackgroundMethodSelf-citationGlutamate Is a Positive Autocrine Signal for Glucagon Release
Cabrera, O., Jacques-Silva, M. C., Speier, S., Yang, S.-N., Köhler, M., Fachado, A., Vieira, E., Zierath, J. R., Kibbey, R., Berman, D. M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.004 · Cited by 217
Cited by
Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men
Rorsman, P., & Ashcroft, F. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00008.2017 · Cited by 793
Paracrine regulation of glucagon secretion: the β/α/δ model
Watts, M., Ha, J., Kimchi, O., & Sherman, A. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00415.2015 · Cited by 53
Metadata
- Authors
- Gylfe, E., & Tengholm, A.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2014-09
- Volume
- 16
- Issue
- S1
- Pages
- 102-110
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2064286821
- Cited by
- 64
- References
- 23
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.